Navigation Links
Catalent Executives Invited to Speak on Patient Perceptions and Alternative Clinical Trial Supply Models at Upcoming ISPE Annual Conference

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Ms. Esther Sadler-Williams, Global Director, Strategic Development and Innovation, and Dr. Paul Ingram, Global Director, Clinical Supply Services, have been invited to speak at the upcoming ISPE Europe Annual Conference, to be held at the Campus Westend, Goethe-Universität, Frankfurt, Germany, on March 7th – 9th, 2016.

Ms. Sadler-Williams’ presentation, on Tuesday March 8th, at 2:00 p.m., is entitled “Patient Perceptions of Investigational Medicinal Products”. She will speak as a representative of the Investigational Products Community of Practice Steering Committee, and discuss the findings from the cross-industry group’s patient survey, undertaken with a range of subjects associated with IMP (Investigational Medicinal Product) trials. The presentation will outline key findings including overall patient experience, patient perceptions around labelling and kit design, transport and storage of medicines, as well as behavior associated with returning unused medicines.

Dr. Ingram is to present “New Supply Chain Concepts and Innovations: Demand Led Supplies” on Wednesday March 9th, at 9:10 a.m., and will discuss the evolution of clinical supply models, examining how challenges within traditional models are driving change within the industry. He will give an overview of the Demand Led Supply (DLS) model, and how it impacts patients, clinical sites, clinical personnel and study sponsors, and the advantages of using a DLS model when appropriate versus traditional supply-led approaches.

Ms. Sadler-Williams M.Sc., MRPharmS, is the past EU chair of the ISPE Investigational Products Community of Practice committee. As a pharmacist, she has had nearly 30 years’ experience in various pharmaceutical fields, latterly in clinical supply environments, but she also worked for five years with Sanofi Winthrop, where she was Head of Research Services, managing groups of clinical research associates, medical writers and information/adverse event surveillance specialists. Her previous roles include Principal Pharmacist with the Regional Drug Information Service at St Mary’s Hospital in Manchester, UK, and Pharmacy Manager with Boots the Chemist.

Dr. Ingram’s 25 year career has focused on Medical Device and Pharmaceutical Research and Development. He obtained his Ph.D. in Pharmaceutical Development from Strathclyde University, Scotland, and has over 15 years of experience in clinical supplies, working both in phase I units and trial supplies service companies including Quintiles (Aptuit), Fisher Clinical and Catalent.

For more information on the 2016 ISPE Europe Annual Conference, visit: and to arrange a meeting with attending Catalent executives at the event, contact Richard Kerns at NEPR- richard(at)nepr(dot)eu.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

More products. Better treatments. Reliably supplied.™

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
2. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
3. Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
4. Catalent and Minomic Collaborate to Bring New Prostate Cancer Treatment to Market
5. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
6. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
7. Catalent Announces Two Senior Appointments to its Biologics Business
8. Bioavailability and Controlled Release Symposium Announced by Catalent Applied Drug Delivery Institute
9. Best Practice and Strategies in Risk Mitigation to be Presented by Catalent Expert at Internal Audit Summit
10. New OptiPact™ Technology Introduced by Catalent
11. Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments
Post Your Comments:
(Date:8/31/2020)... ... , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), part ... (CMU) to develop a new heart monitoring device designed to serve as an ... AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes of ...
(Date:8/31/2020)... ... 2020 , ... Just found out your dear friend has cancer? , It’s hard to hear ... member shares their diagnosis. Once the shock wears off, the questions and fears can be ... the best ways to help? Words are failing me. I’m scared. I want to DO ...
(Date:8/31/2020)... ... August 31, 2020 , ... Want to get moving, break up your ... Foundation (CPARF) is thrilled to launch its fourth annual STEPtember campaign in the United ... STEPtember meets everyone wherever they are at this moment — encouraging people to move ...
(Date:8/31/2020)... ... 31, 2020 , ... Colorado State University Global (CSU Global) ... online education – is proud to announce its new master’s degree in ... kind in the nation, the 60-credit hour program is designed to provide students ...
(Date:8/31/2020)... ... ... topsy-turvy economic outlook continues to put financial strain on many of us, so it just ... our monthly expenses and put more into savings, if possible. , “That’s a great way ... net in place in case something were to happen to you,” says Lee Duncan, CMO ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... (PRWEB) , ... September 02, 2020 , ... U.S. ... Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. ... his B.A. from the University of California, Berkley. He went on to receive his ...
(Date:9/1/2020)... ... September 01, 2020 , ... Neil Oberfeld of ... Secretary to the Board of Trustees and committee chair of the Governance Committee ... a Denver-based nonprofit organization that fights for the education, health, and financial stability ...
(Date:9/1/2020)... ... 01, 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian ... other cancer of the female reproductive system. The American Cancer Society estimates that ... women will die from this disease. Throughout the month of September, Women’s Excellence ...
Breaking Medicine Technology: